TL;DR
- Latest Buy Boosts Holdings: Semler Scientific acquired 185 BTC for $20 million, increasing its total Bitcoin holdings to 4,449 coins, and showcasing robust confidence in digital assets.
- Innovative Funding Strategy: The firm raised approximately $136.2 million through its at-the-market (ATM) common stock program to fund the expansion of its Bitcoin treasury.
- Institutional Endorsement: With a Bitcoin portfolio now valued at nearly $467 million and a BTC Yield of 26.7% year-to-date, Semler Scientific remains among the top 15 corporate Bitcoin holders, reinforcing its long-term investment strategy.
Nasdaq-listed healthcare technology firm Semler Scientific has made headlines with its latest acquisition in the corporate Bitcoin accumulation race. From May 23 to June 3, the company bought another 185 BTC for about $20 million, increasing its total Bitcoin holdings to 4,449. This latest buy not only underscores the firm’s growing confidence in digital assets but also marks a significant step in its broader investment strategy.
Strategic Bitcoin Acquisition
Semler Scientific recently bought Bitcoin at an average price of about $107,974 each. Despite the significant price per coin, these acquisitions have allowed the company to amass a substantial Bitcoin treasury now valued at nearly $467 million in today’s market.
The latest buy, when combined with its previous investments, has resulted in about $57 million in paper gains relative to the company’s overall acquisition cost. This achievement places Semler Scientific among the top 15 corporate holders of Bitcoin, signifying a strong institutional endorsement of the digital asset as a long-term treasury strategy.
Funding Through the ATM Program
The funding for this strategic Bitcoin expansion came from an innovative approach. Semler Scientific tapped into its at-the-market (ATM) common stock program, partnering with renowned financial institutions to raise capital. With an agreement in place to sell up to $500 million of its common shares, the company raised net proceeds of approximately $136.2 million.
This infusion of funds has been pivotal, allowing the firm to pursue Bitcoin acquisitions while maintaining its core operations in medical-grade technology and chronic disease detection. By leveraging the ATM program, Semler Scientific has demonstrated the evolving financing methods that bridge traditional markets and the emerging crypto asset space.
Implications for Corporate Crypto Portfolios
The continued investment in Bitcoin adds momentum to the trend of corporate digital asset accumulation. Semler Scientific’s BTC Yield stands at an impressive 26.7% year-to-date. This not only boosts shareholder value but also signals growing institutional interest in digital assets as a hedge against market volatility.
